Intellia Therapeutics (NTLA) EBIT Margin Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,225.00 |
| Dec 31, 2025 | 21,404.00 |
| Sep 30, 2025 | -68,239.00 |
| Jun 30, 2025 | -56,905.00 |
| Mar 31, 2025 | -6,561.00 |
| Dec 31, 2024 | -78,764.00 |
| Sep 30, 2024 | -135,038.00 |
| Jun 30, 2024 | -175,162.00 |
| Mar 31, 2024 | -16,579.00 |
| Dec 31, 2023 | 756,072.00 |
| Sep 30, 2023 | -76,798.00 |
| Jun 30, 2023 | -66,613.00 |
| Mar 31, 2023 | -58,782.00 |
| Dec 31, 2022 | -44,042.00 |
| Sep 30, 2022 | -57,853.00 |
| Jun 30, 2022 | -42,995.00 |
| Mar 31, 2022 | -107,362.00 |
| Dec 31, 2021 | -43,328.00 |
| Sep 30, 2021 | -2.38 Mn |
| Jun 30, 2021 | -88,855.00 |
| Mar 31, 2021 | -34,362.00 |
| Dec 31, 2020 | -31,856.00 |
| Sep 30, 2020 | 6,909.00 |
| Jun 30, 2020 | 4,539.00 |
| Mar 31, 2020 | -56,804.00 |